| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |